← Leaderboards
Anil K Chandraker
Brigham And Women'S Hospital
$3,270,888
Attributed
$3,665,214
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–13$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$3,665,214 · 5
By mechanism
U01$2,543,579 · 1
K08$621,000 · 1
R24$492,908 · 1
M01$7,727 · 2
Top collaborators
- Laura M Dember1 shared
- Robert E Gerszten1 shared
- Martin R. Pollak1 shared
- Ravi Thadhani1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Gregory L Stahl$14,189,628
- Francis D Moore$4,657,409
- Reza Abdi$32,829,278
- Charles Nicholas Serhan$33,627,216
- Marc S Sabatine$10,458,271
Others in their field
Top investigators on “Isoantigen”
- Bruce R. Blazar · University Of Minnesota$4,435,519
- Jonathan Sprent · Scripps Research Institute$3,089,326
- Richard Herbert Aster · Bloodcenter Of Wisconsin, Inc.$2,606,431
- Claudio Anasetti · Fred Hutchinson Cancer Research Center$2,154,014
- Beverly J Torok-Storb · Fred Hutchinson Cancer Research Center$2,131,084
- David S Wilkes · Indiana Univ-Purdue Univ At Indianapolis$1,991,091
Research focus
IsoantigenT LymphocytePathologic ProcessModel Design /DevelopmentDisease /Disorder ModelPassive ImmunizationIschemiaLaboratory RatHomologous TransplantationKidney TransplantationCd40 MoleculeReperfusionCyclosporinesTransplant RejectionCd AntigensPreventPharmaceutical PreparationsInstitutionTransplantationResearch PersonnelAntibodiesPurposeB-LymphocytesInjury To Kidney
Grant awards (9)
Novel Therapies to Improve Renal and Cardiac Allograft Outcomes$2,543,579
U01 · FY2013 · AI · contact PI
Clinical characterization of the APOL1-associated phenotype$492,908
R24 · FY2011 · DK
B-CELL DEPLETION BY ANTI-CD20 (RITUXIMAB)$1,003
M01 · FY2008 · RR · contact PI
B-CELL DEPLETION BY ANTI-CD20 (RITUXIMAB)$6,724
M01 · FY2007 · RR · contact PI
The CD40-CD154 pathway in chronic allograft rejection$128,520
K08 · FY2005 · AI
The CD40-CD154 pathway in chronic allograft rejection$128,520
K08 · FY2004 · AI
The CD40-CD154 pathway in chronic allograft rejection$128,520
K08 · FY2003 · AI
The CD40-CD154 pathway in chronic allograft rejection$117,720
K08 · FY2002 · AI
The CD40-CD154 pathway in chronic allograft rejection$117,720
K08 · FY2001 · AI